A new study addresses the "holy grail" in thyroid oncology: how to jump-start radioactive iodine treatment when it stops working for patients with thyroid cancer. The investigators report that a ...
TAZNI: A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results